CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 365 enrolled
Drug / intervention
Computer reminder systembehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01343485
NCT01343485N/ACompleted

Staying on Track: Increasing Completion of the HPV Vaccine Series With the Use of an Innovative Patient and Provider Information and Tracking Tool

Planned Parenthood Federation of America·interventional·Posted Apr 28, 2011·Updated Jun 26, 2018

In Brief

A clinical study evaluating Computer reminder system for GARDASIL Vaccination. Completed, enrolled 365 participants across 9 sites.

Detailed Summary

Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 28, 2011
Enrollment StartSep 1, 2011
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 15.2 years ago

Interventions

Computer reminder systembehavioral

Intervention sites will receive computer kiosk with study specific software to assist in reminding study participants to return for HPV vaccine series